The global heparin API market in terms of revenue is set to grow by US$ 1 billion during 2021-2027, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period, according to data and analytics company StrategyHelix.
The report provides up-to-date market size data for period 2017-2020 and forecast to 2027 covering key market aspects like sales value for heparin API. The global heparin API market is segmented on the basis of region, price. By region, it is categorized into China, Europe, USA, and others. By price, the heparin API market is divided into casing, crude heparin, heparin API, and porcine small intestine.
The report has profiled some of the key players of the market such as Shenzhen Hepalink Pharmaceutical Group Co. Ltd., Bioiberica S.A.U., Changzhou Qianhong Biopharma Co. Ltd., Hebei Changshan Biochemical Pharmaceutical Co. Ltd..
The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the heparin API market to help drive informed decision making for industry executives, policy makers, academic, and analysts.
Region: China, Europe, USA, and others
Price: casing, crude heparin, heparin API, and porcine small intestine
Years Considered: this report covers the period 2017 to 2027
Key Benefits for Stakeholders
Get a comprehensive picture of the global heparin API market
Pinpoint growth sectors and trends for investment
Understand what the future of the global heparin API market looks like
Identify the competitive landscape and window of opportunity
Table of Contents
1. Market Definition
2. Research Methodology
3. Market Data & Outlook
3.1 Market Value
3.2 Market Value Forecast
4. Heparin API Market by Region
5. Heparin API Market by Price
5.2 Crude Heparin
5.3 Heparin Api
5.4 Porcine Small Intestine
6. Company Profiles
6.1 Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
6.2 Bioiberica S.A.U.
6.3 Changzhou Qianhong Biopharma Co., Ltd.
6.4 Hebei Changshan Biochemical Pharmaceutical Co., Ltd.
7.1 About StrategyHelix